Search results for: Vaccines
Filter search results
Virtual OHE Annual Lecture 2021: Do Patents Work? Evidence from Pharmaceutical Innovation
14 October 2021, 1:00pm
…remain a contentious tool in innovation policy, as seen in the current debate over the proposed patent waiver for COVID vaccines, she will also discuss the empirical evidence concerning alternatives…
Opportunity Cost in Health Care: a Favourite Research Topic for OHE
23 November 2021
…opportunity costs beyond health. To this end, we’ve recently been researching how different government departments value life. Most recently, we’ve been exploring the role of vaccines in maintaining health system…
OHE Innovation Policy Prize
18 May 2022
…life sciences delivers for each and every one of us. The record-breaking development of multiple COVID-19 vaccines, potential curative gene therapies for spinal muscular atrophy, or even the antibiotics which…
Finance of Medical Research
7 January 1964
…work gave rise to the study of infections and the processes of immunity leading to the development of vaccines and serum treatment and culminated in the discovery and development of…
Pharmaceutical Innovation: Recent Trends, Future Prospects
1 October 1983
…effective vaccines has not, however, been restricted to tuberculosis alone: notifications data (Table 1) and mortality statistics (Table 2) indicate that there have also been major reductions in the incidence…
AIDS Virus: Forecasting Its Impact
1 December 1986
…the nation’ (Acheson 1986). Reconciliation of the two seemingly conflicting perspectives outlined above is. however, straightforward. AIDS is a new disease in man that is invariably lethal. Effective vaccines and…
Narrowing the Gap between provision and need for medicines in developing countries
1 February 2000
…that proposed by Jeffrey Sachs and Michael Kremer for malaria, TB, and HIV vaccines, would provide companies with the assurance that if their R&D were successful, then there would be…
Incentives for New Drugs to Tackle Anti-Microbial Resistance
1 May 2017
…medicines. Pull incentives are key to stimulating R&D for new antibiotics and vaccines. In this Briefing we look at the proposals in the 2016 O’Neill Report commissioned by the UK…
Adrian Towse
6 February 2014
…School of Economics. Adrian’s current research interests include incentives for new drugs and vaccines to tackle Antimicrobial Resistance; the use of ‘risk– sharing’ arrangements between health care payers and pharmaceutical…